{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:32:25Z","timestamp":1789122745160,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.humpath.2026.106264","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:09:51Z","timestamp":1788995391000},"page":"106264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sarcomatoid malignancies with strong PD-L1 expression often represent dedifferentiated or undifferentiated melanomas"],"prefix":"10.1016","author":[{"given":"Aubre D.","family":"Gilbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryanne A.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.W.","family":"Twa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex Q.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1366-517X","authenticated-orcid":false,"given":"Clara","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2715-2779","authenticated-orcid":false,"given":"Hubert D.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4444-0297","authenticated-orcid":false,"given":"John M.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam","family":"Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2774-2704","authenticated-orcid":false,"given":"Gregory W.","family":"Charville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2026.106264_bib1","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1038\/s41379-021-00857-z","article-title":"The clinicopathologic spectrum and genomic landscape of de-\/trans-differentiated melanoma","volume":"34","author":"Ferreira","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106264_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/PAS.0000000000000527","article-title":"Metastatic malignant melanoma with complete loss of differentiation markers (Undifferentiated\/Dedifferentiated melanoma): analysis of 14 patients emphasizing phenotypic plasticity and the value of molecular testing as surrogate diagnostic marker","volume":"40","author":"Agaimy","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106264_bib3","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/PAS.0000000000001645","article-title":"Dedifferentiated and undifferentiated melanomas: report of 35 new cases with literature review and proposal of diagnostic criteria","volume":"45","author":"Agaimy","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106264_bib4","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/his.12305","article-title":"BRAF mutation in \u201csarcomas\u201d: a possible method to detect de-differentiated melanomas","volume":"64","author":"Cipriani","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2026.106264_bib5","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/PAS.0000000000002390","article-title":"Molecular analysis of cutaneous sarcomatoid neoplasms frequently identifies melanoma driver variants","volume":"49","author":"Jackett","year":"2025","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106264_bib6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/his.15309","article-title":"The utility of DNA methylation profiling in the diagnosis of un-, de- and trans-differentiated melanoma: a series of 11 cases","volume":"86","author":"Erdem","year":"2025","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2026.106264_bib7","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/PAS.0000000000002125","article-title":"PRAME expression is a useful tool in the diagnosis of primary and metastatic dedifferentiated and undifferentiated melanoma","volume":"47","author":"Hornick","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106264_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100165","article-title":"Undifferentiated and dedifferentiated metastatic Melanomas masquerading as soft tissue sarcomas: mutational signature analysis and immunotherapy response","volume":"36","author":"Kasago","year":"2023","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106264_bib9","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2026.106264_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa2407417","article-title":"Final, 10-Year outcomes with Nivolumab plus ipilimumab in advanced melanoma","volume":"392","author":"Wolchok","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2026.106264_bib11","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1097\/PAS.0b013e31822280d8","article-title":"Metastatic melanoma with striking adenocarcinomatous differentiation illustrating phenotypic plasticity in melanoma","volume":"35","author":"Jalas","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106264_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/php.12377","article-title":"UV signature mutations","volume":"91","author":"Brash","year":"2015","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.humpath.2026.106264_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100626","article-title":"A comparative genomic study of conventional and undifferentiated melanoma","volume":"37","author":"Fischer","year":"2024","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106264_bib14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jaad.2005.03.006","article-title":"Completely regressed primary cutaneous malignant melanoma with nodal and\/or visceral metastases: a report of 5 cases and assessment of the literature and diagnostic criteria","volume":"53","author":"High","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.humpath.2026.106264_bib15","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2026.106264_bib16","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa1603702","article-title":"PD-1 blockade with pembrolizumab in advanced merkel-cell carcinoma","volume":"374","author":"Nghiem","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2026.106264_bib17","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1158\/0008-5472.CAN-12-2384","article-title":"Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma","volume":"73","author":"Lyford-Pike","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2026.106264_bib18","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa2303383","article-title":"Atezolizumab for advanced alveolar soft part sarcoma","volume":"389","author":"Chen","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2026.106264_bib19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s40425-019-0689-7","article-title":"Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution","volume":"7","author":"Florou","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.humpath.2026.106264_bib20","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.7150\/jca.19060","article-title":"Programmed death ligand 1 (PD-L1) expression in primary Angiosarcoma","volume":"8","author":"Botti","year":"2017","journal-title":"J Cancer"},{"key":"10.1016\/j.humpath.2026.106264_bib21","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/PAS.0000000000002387","article-title":"Malignant giant cell tumor of bone: a clinicopathologic series of 28 cases highlighting genetic differences compared with conventional, atypical, and metastasizing conventional tumors","volume":"49","author":"Papke","year":"2025","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106264_bib22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/cup.13841","article-title":"PD-1 and PD-L1 expression in Kaposi sarcoma: a comparative study according to the pathological stage and clinical characteristics","volume":"48","author":"Kim","year":"2021","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.humpath.2026.106264_bib23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.anndiagpath.2016.05.003","article-title":"Follicular dendritic cell sarcoma: clinicopathologic study of 15 cases with emphasis on novel expression of MDM2, somatostatin receptor 2A, and PD-L1","volume":"23","author":"Agaimy","year":"2016","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.humpath.2026.106264_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAS.0000000000002327","article-title":"Neurofibroma-like desmoplastic melanoma: a series of five cases exploring the role of molecular testing as a diagnostic adjunct and highlighting the differential diagnosis with diffuse-type neurofibroma","volume":"49","author":"Baraban","year":"2025","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106264_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00428-023-03606-6","article-title":"PRAME immunohistochemistry in soft tissue tumors and mimics: a study of 350 cases highlighting its imperfect specificity but potentially useful diagnostic applications","volume":"483","author":"Cammareri","year":"2023","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2026.106264_bib26","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1038\/jid.2013.197","article-title":"Transcriptome profiling identifies HMGA2 as a biomarker of melanoma progression and prognosis","volume":"133","author":"Raskin","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.humpath.2026.106264_bib27","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/PAS.0000000000002452","article-title":"Undifferentiated melanoma: a clinicopathologic and gene expression analysis study with identification of HMGA2 as a diagnostic marker","volume":"49","author":"Fischer","year":"2025","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106264_bib28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/PAS.0000000000002138","article-title":"Assessment of the utility of the sarcoma DNA methylation classifier in surgical pathology","volume":"48","author":"Miettinen","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106264_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.semdp.2026.151032","article-title":"Pleomorphic sarcomas and mimics - a practical algorithmic approach to avoid pitfalls","volume":"43","author":"Gross","year":"2026","journal-title":"Semin Diagn Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726002339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726002339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:37:28Z","timestamp":1789119448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817726002339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":29,"alternative-id":["S0046817726002339"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106264","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sarcomatoid malignancies with strong PD-L1 expression often represent dedifferentiated or undifferentiated melanomas","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106264"}}